Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025
Adaptive Biotechnologies (Nasdaq: ADPT) has announced it will release its fourth quarter and full year 2024 financial results after market close on Tuesday, February 11, 2025. The company will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day to discuss the results. Investors can access the live audio webcast through the company's website, and a replay will be available within 24 hours after the event.
Adaptive Biotechnologies (Nasdaq: ADPT) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura del mercato martedì 11 febbraio 2025. L'azienda terrà una conferenza telefonica e un webcast alle 13:30 ora del Pacifico / 16:30 ora dell'Est nello stesso giorno per discutere i risultati. Gli investitori possono accedere al webcast audio dal vivo tramite il sito web dell'azienda e una registrazione sarà disponibile entro 24 ore dopo l'evento.
Adaptive Biotechnologies (Nasdaq: ADPT) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año fiscal 2024 después del cierre del mercado el martes 11 de febrero de 2025. La compañía llevará a cabo una llamada de conferencia y un webcast a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este el mismo día para discutir los resultados. Los inversores pueden acceder al webcast de audio en vivo a través del sitio web de la compañía, y una repetición estará disponible dentro de 24 horas después del evento.
Adaptive Biotechnologies (Nasdaq: ADPT)는 2025년 2월 11일 화요일 시장 종료 후 2024년 4분기 및 전체 연도 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 태평양 표준시 오후 1:30 / 동부 표준시 오후 4:30에 결과를 설명하기 위한 컨퍼런스 콜과 웹캐스트를 개최합니다. 투자자들은 회사 웹사이트를 통해 실시간 오디오 웹캐스트에 접근할 수 있으며, 이벤트 발생 후 24시간 이내에 다시 볼 수 있는 서비스를 제공합니다.
Adaptive Biotechnologies (Nasdaq: ADPT) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année 2024 après la fermeture du marché le mardi 11 février 2025. L'entreprise organisera une conférence téléphonique et un webcast le même jour à 13h30 heure du Pacifique / 16h30 heure de l'Est pour discuter des résultats. Les investisseurs peuvent accéder au webcast audio en direct via le site web de l'entreprise, et un enregistrement sera disponible dans les 24 heures suivant l'événement.
Adaptive Biotechnologies (Nasdaq: ADPT) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 nach Marktende am Dienstag, den 11. Februar 2025, veröffentlichen wird. Das Unternehmen wird am selben Tag um 13:30 Uhr Pazifischer Zeit / 16:30 Uhr Eastern Time eine Telefonkonferenz und ein Webcast abhalten, um die Ergebnisse zu besprechen. Investoren können über die Unternehmenswebsite auf den Live-Audio-Webcast zugreifen, und eine Wiederholung wird innerhalb von 24 Stunden nach der Veranstaltung verfügbar sein.
- None.
- None.
SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the fourth quarter and full year 2024 after market close on Tuesday, February 11, 2025. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the “Investors” section of the company website at: www.adaptivebiotech.com. The webcast will be archived and available for replay within 24 hours after the event.
About Adaptive Biotechnologies
Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. We believe the adaptive immune system is nature’s most finely tuned diagnostic and therapeutic for most diseases, but the inability to decode it has prevented the medical community from fully leveraging its capabilities. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. We apply our platform to partner with biopharmaceutical companies, inform drug development, and develop clinical diagnostics across our two business areas: Minimal Residual Disease (MRD) and Immune Medicine. Our commercial products and clinical pipeline enable the diagnosis, monitoring, and treatment of diseases such as cancer, autoimmune disorders, and infectious diseases. Our goal is to develop and commercialize immune-driven clinical products tailored to each individual patient.
ADAPTIVE INVESTORS
Karina Calzadilla, Vice President, Investor Relations
201-396-1687
investors@adaptivebiotech.com
ADAPTIVE MEDIA
Erica Jones, Associate Director, Corporate Communications
206-279-2423
media@adaptivebiotech.com
FAQ
When will Adaptive Biotechnologies (ADPT) release Q4 2024 earnings?
What time is ADPT's Q4 2024 earnings call?
How can investors access ADPT's Q4 2024 earnings call?
Will ADPT's Q4 2024 earnings call be available for replay?
